Preclinical studies subsequently revealed that some molecules targeting PTPs are able to slow down proliferation and reduce the metastatic dissemination of many aggressive forms of cancers without producing side effects, suggesting the possibility of introducing these compounds in the therapy against melanoma [21,231]. The gene discussed is PTS; the disease is cancer.